Skip to main content
Erschienen in: Clinical Research in Cardiology 12/2015

01.12.2015 | Review

Cardiac surgery 2014 reviewed

verfasst von: Torsten Doenst, Constanze Strüning, Alexandros Moschovas, David Gonzalez-Lopez, Ilija Valchanov, Hristo Kirov, Mahmoud Diab, Gloria Faerber

Erschienen in: Clinical Research in Cardiology | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

For the year 2014, more than 17,000 published references can be found in Pubmed when entering the search term “cardiac surgery”. The last year has been characterized by a vivid discussion in the fields where classic cardiac surgery and modern interventional techniques overlap. Specifically, there have been important contributions in the field of coronary revascularization with either percutaneous coronary intervention or bypass surgery as well as in the fields of interventional valve therapy. Here, the US core valve trial with the first demonstration of a survival advantage at 1 year with transcatheter valves compared to surgical aortic valve replacement or the 5-year outcome of the SYNTAX trial with significant advantages for bypass surgery has been the landmark. However, in addition to these most visible publications, there have been several highly relevant and interesting contributions. This review article will summarize the most pertinent publications in the fields of coronary revascularization, surgical treatment of valve disease, heart failure (i.e., transplantation and ventricular assist devices) and aortic surgery. This condensed summary will provide the reader with “solid ground” for up-to-date decision-making in cardiac surgery.
Literatur
1.
Zurück zum Zitat Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C (2014) Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Int Med 174(2):223–230. doi:10.1001/jamainternmed.2013.12844 CrossRef Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C (2014) Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Int Med 174(2):223–230. doi:10.​1001/​jamainternmed.​2013.​12844 CrossRef
2.
Zurück zum Zitat Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Stahle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW (2014) Coronary artery bypass grafting versus percutaneous coronary intervention for patients with three-vessel disease: final 5 year follow-up of the SYNTAX trial. Eur Heart J 35(40):2821–2830. doi:10.1093/eurheartj/ehu213 CrossRefPubMed Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Stahle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW (2014) Coronary artery bypass grafting versus percutaneous coronary intervention for patients with three-vessel disease: final 5 year follow-up of the SYNTAX trial. Eur Heart J 35(40):2821–2830. doi:10.​1093/​eurheartj/​ehu213 CrossRefPubMed
3.
Zurück zum Zitat Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, Gradinac S, Chrzanowski L, Prabhakaran D, Howlett JG, Jasinski M, Hill JA, Szwed H, Larbalestier R, Desvigne-Nickens P, Jones RH, Lee KL, Rouleau JL (2014) Extent of coronary and myocardial disease and benefit from surgical revascularization in LV dysfunction. J Am Coll Cardiol 64(6):553–561. doi:10.1016/j.jacc.2014.04.064 PubMedCentralCrossRefPubMed Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, Gradinac S, Chrzanowski L, Prabhakaran D, Howlett JG, Jasinski M, Hill JA, Szwed H, Larbalestier R, Desvigne-Nickens P, Jones RH, Lee KL, Rouleau JL (2014) Extent of coronary and myocardial disease and benefit from surgical revascularization in LV dysfunction. J Am Coll Cardiol 64(6):553–561. doi:10.​1016/​j.​jacc.​2014.​04.​064 PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Dangas GD, Farkouh ME, Sleeper LA, Yang M, Schoos MM, Macaya C, Abizaid A, Buller CE, Devlin G, Rodriguez AE, Lansky AJ, Siami FS, Domanski M, Fuster V, Investigators F (2014) Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. J Am Coll Cardiol 64(12):1189–1197. doi:10.1016/j.jacc.2014.06.1182 CrossRefPubMed Dangas GD, Farkouh ME, Sleeper LA, Yang M, Schoos MM, Macaya C, Abizaid A, Buller CE, Devlin G, Rodriguez AE, Lansky AJ, Siami FS, Domanski M, Fuster V, Investigators F (2014) Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. J Am Coll Cardiol 64(12):1189–1197. doi:10.​1016/​j.​jacc.​2014.​06.​1182 CrossRefPubMed
5.
Zurück zum Zitat Kumada Y, Ishii H, Aoyama T, Kamoi D, Kawamura Y, Sakakibara T, Nogaki H, Takahashi H, Murohara T (2014) Long-term clinical outcome after surgical or percutaneous coronary revascularization in hemodialysis patients. Circ J 78(4):986–992CrossRefPubMed Kumada Y, Ishii H, Aoyama T, Kamoi D, Kawamura Y, Sakakibara T, Nogaki H, Takahashi H, Murohara T (2014) Long-term clinical outcome after surgical or percutaneous coronary revascularization in hemodialysis patients. Circ J 78(4):986–992CrossRefPubMed
6.
Zurück zum Zitat Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A (2014) Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. JACC Cardiovasc Interventions 7(4):354–361. doi:10.1016/j.jcin.2013.11.014 CrossRef Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A (2014) Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. JACC Cardiovasc Interventions 7(4):354–361. doi:10.​1016/​j.​jcin.​2013.​11.​014 CrossRef
7.
Zurück zum Zitat Blazek S, Rossbach C, Borger MA, Fuernau G, Desch S, Eitel I, Stiermaier T, Lurz P, Holzhey D, Schuler G, Mohr FW, Thiele H (2014) Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7 year follow-up of a randomized trial. JACC Cardiovasc Interventions. doi:10.1016/j.jcin.2014.08.006 Blazek S, Rossbach C, Borger MA, Fuernau G, Desch S, Eitel I, Stiermaier T, Lurz P, Holzhey D, Schuler G, Mohr FW, Thiele H (2014) Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7 year follow-up of a randomized trial. JACC Cardiovasc Interventions. doi:10.​1016/​j.​jcin.​2014.​08.​006
8.
Zurück zum Zitat Deo SV, Sharma V, Shah IK, Erwin PJ, Joyce LD, Park SJ (2014) Minimally invasive direct coronary artery bypass graft surgery or percutaneous coronary intervention for proximal left anterior descending artery stenosis: a meta-analysis. Ann Thorac Surg 97(6):2056–2065. doi:10.1016/j.athoracsur.2014.01.086 CrossRefPubMed Deo SV, Sharma V, Shah IK, Erwin PJ, Joyce LD, Park SJ (2014) Minimally invasive direct coronary artery bypass graft surgery or percutaneous coronary intervention for proximal left anterior descending artery stenosis: a meta-analysis. Ann Thorac Surg 97(6):2056–2065. doi:10.​1016/​j.​athoracsur.​2014.​01.​086 CrossRefPubMed
10.
Zurück zum Zitat Hoffman DM, Dimitrova KR, Lucido DJ, Dincheva GR, Geller CM, Balaram SK, Ko W, Swistel DG, Tranbaugh RF (2014) Optimal conduit for diabetic patients: propensity analysis of radial and right internal thoracic arteries. Ann Thorac Surg 98(1):30–36. doi:10.1016/j.athoracsur.2014.03.044 (discussion 36–37) CrossRefPubMed Hoffman DM, Dimitrova KR, Lucido DJ, Dincheva GR, Geller CM, Balaram SK, Ko W, Swistel DG, Tranbaugh RF (2014) Optimal conduit for diabetic patients: propensity analysis of radial and right internal thoracic arteries. Ann Thorac Surg 98(1):30–36. doi:10.​1016/​j.​athoracsur.​2014.​03.​044 (discussion 36–37) CrossRefPubMed
11.
Zurück zum Zitat Moss E, Puskas JD, Thourani VH, Kilgo P, Chen EP, Leshnower BG, Lattouf OM, Guyton RA, Glas KE, Halkos ME (2015) Avoiding aortic clamping during coronary artery bypass grafting reduces postoperative stroke. J Thorac Cardiovasc Surg 149(1):175–180. doi:10.1016/j.jtcvs.2014.09.011 CrossRefPubMed Moss E, Puskas JD, Thourani VH, Kilgo P, Chen EP, Leshnower BG, Lattouf OM, Guyton RA, Glas KE, Halkos ME (2015) Avoiding aortic clamping during coronary artery bypass grafting reduces postoperative stroke. J Thorac Cardiovasc Surg 149(1):175–180. doi:10.​1016/​j.​jtcvs.​2014.​09.​011 CrossRefPubMed
12.
Zurück zum Zitat Cavallaro P, Itagaki S, Seigerman M, Chikwe J (2014) Operative mortality and stroke after on-pump vs off-pump surgery in high-risk patients: an analysis of 83,914 coronary bypass operations. Eur J Cardiothorac Surg 45(1):159–164. doi:10.1093/ejcts/ezt221 CrossRefPubMed Cavallaro P, Itagaki S, Seigerman M, Chikwe J (2014) Operative mortality and stroke after on-pump vs off-pump surgery in high-risk patients: an analysis of 83,914 coronary bypass operations. Eur J Cardiothorac Surg 45(1):159–164. doi:10.​1093/​ejcts/​ezt221 CrossRefPubMed
13.
14.
15.
Zurück zum Zitat Authors/Task Force m, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Torracca L, Valgimigli M, Wijns W, Witkowski A, Authors/Task Force m (2014) ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35(37):2541–2619 10.1093/eurheartj/ehu278 CrossRef Authors/Task Force m, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Torracca L, Valgimigli M, Wijns W, Witkowski A, Authors/Task Force m (2014) ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35(37):2541–2619 10.​1093/​eurheartj/​ehu278 CrossRef
16.
Zurück zum Zitat Windecker S, Stortecky S, Stefanini GG, da Costa BR, Rutjes AW, Di Nisio M, Silletta MG, Maione A, Alfonso F, Clemmensen PM, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter D, Schauerte P, Sousa Uva M, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, Kolh P, Juni P (2014) Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ 348:g3859. doi:10.1136/bmj.g3859 PubMedCentralCrossRefPubMed Windecker S, Stortecky S, Stefanini GG, da Costa BR, Rutjes AW, Di Nisio M, Silletta MG, Maione A, Alfonso F, Clemmensen PM, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter D, Schauerte P, Sousa Uva M, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, Kolh P, Juni P (2014) Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ 348:g3859. doi:10.​1136/​bmj.​g3859 PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat de Waha A, Cassese S, Park DW, Burzotta F, Byrne RA, Tada T, King LA, Park SJ, Schomig A, Kastrati A (2012) Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials. Clin Res Cardiol 101(6):461–467. doi:10.1007/s00392-012-0414-8 CrossRefPubMed de Waha A, Cassese S, Park DW, Burzotta F, Byrne RA, Tada T, King LA, Park SJ, Schomig A, Kastrati A (2012) Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials. Clin Res Cardiol 101(6):461–467. doi:10.​1007/​s00392-012-0414-8 CrossRefPubMed
18.
Zurück zum Zitat Akin I, Hochadel M, Abdel-Wahab M, Senges J, Richardt G, Schneider S, Tebbe U, Kuck KH, Nienaber CA (2013) Clinical outcomes of different first- and second-generation drug-eluting stents in routine clinical practice: results from the prospective multicenter German DES.DE registry. Clin Res Cardiol 102(5):371–381. doi:10.1007/s00392-013-0546-5 CrossRefPubMed Akin I, Hochadel M, Abdel-Wahab M, Senges J, Richardt G, Schneider S, Tebbe U, Kuck KH, Nienaber CA (2013) Clinical outcomes of different first- and second-generation drug-eluting stents in routine clinical practice: results from the prospective multicenter German DES.DE registry. Clin Res Cardiol 102(5):371–381. doi:10.​1007/​s00392-013-0546-5 CrossRefPubMed
19.
Zurück zum Zitat Akin I, Naber C, Sabin G, Hochadel M, Senges J, Kuck KH, Nienaber C, Richardt G, Tolg R (2013) Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry. Clin Res Cardiol 102(9):679–686. doi:10.1007/s00392-013-0582-1 CrossRefPubMed Akin I, Naber C, Sabin G, Hochadel M, Senges J, Kuck KH, Nienaber C, Richardt G, Tolg R (2013) Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry. Clin Res Cardiol 102(9):679–686. doi:10.​1007/​s00392-013-0582-1 CrossRefPubMed
20.
Zurück zum Zitat Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK, Investigators USCC (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370(19):1790–1798. doi:10.1056/NEJMoa1400590 CrossRefPubMed Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK, Investigators USCC (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370(19):1790–1798. doi:10.​1056/​NEJMoa1400590 CrossRefPubMed
21.
Zurück zum Zitat Mohr FW, Holzhey D, Mollmann H, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Bohm M, Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Hamm CW, Board GE (2014) The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease. Eur J Cardiothorac Surg 46(5):808–816. doi:10.1093/ejcts/ezu290 CrossRefPubMed Mohr FW, Holzhey D, Mollmann H, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Bohm M, Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Hamm CW, Board GE (2014) The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease. Eur J Cardiothorac Surg 46(5):808–816. doi:10.​1093/​ejcts/​ezu290 CrossRefPubMed
22.
Zurück zum Zitat Williams M, Kodali SK, Hahn RT, Humphries KH, Nkomo VT, Cohen DJ, Douglas PS, Mack M, McAndrew TC, Svensson L, Thourani VH, Tuzcu EM, Weissman NJ, Kirtane AJ, Leon MB (2014) Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 63(15):1522–1528. doi:10.1016/j.jacc.2014.01.036 CrossRefPubMed Williams M, Kodali SK, Hahn RT, Humphries KH, Nkomo VT, Cohen DJ, Douglas PS, Mack M, McAndrew TC, Svensson L, Thourani VH, Tuzcu EM, Weissman NJ, Kirtane AJ, Leon MB (2014) Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 63(15):1522–1528. doi:10.​1016/​j.​jacc.​2014.​01.​036 CrossRefPubMed
23.
Zurück zum Zitat Lindman BR, Pibarot P, Arnold SV, Suri RM, McAndrew TC, Maniar HS, Zajarias A, Kodali S, Kirtane AJ, Thourani VH, Tuzcu EM, Svensson LG, Waksman R, Smith CR, Leon MB (2014) Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 63(11):1090–1099. doi:10.1016/j.jacc.2013.10.057 PubMedCentralCrossRefPubMed Lindman BR, Pibarot P, Arnold SV, Suri RM, McAndrew TC, Maniar HS, Zajarias A, Kodali S, Kirtane AJ, Thourani VH, Tuzcu EM, Svensson LG, Waksman R, Smith CR, Leon MB (2014) Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 63(11):1090–1099. doi:10.​1016/​j.​jacc.​2013.​10.​057 PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Dvir D, Waksman R, Barbash IM, Kodali SK, Svensson LG, Tuzcu EM, Xu K, Minha S, Alu MC, Szeto WY, Thourani VH, Makkar R, Kapadia S, Satler LF, Webb JG, Leon MB, Pichard AD (2014) Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve). J Am Coll Cardiol 63(3):269–279. doi:10.1016/j.jacc.2013.09.024 CrossRefPubMed Dvir D, Waksman R, Barbash IM, Kodali SK, Svensson LG, Tuzcu EM, Xu K, Minha S, Alu MC, Szeto WY, Thourani VH, Makkar R, Kapadia S, Satler LF, Webb JG, Leon MB, Pichard AD (2014) Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve). J Am Coll Cardiol 63(3):269–279. doi:10.​1016/​j.​jacc.​2013.​09.​024 CrossRefPubMed
25.
Zurück zum Zitat Onorati F, D’Errigo P, Grossi C, Barbanti M, Ranucci M, Covello DR, Rosato S, Maraschini A, Santoro G, Tamburino C, Seccareccia F, Santini F, Menicanti L, Group OR (2014) Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study. J Thorac Cardiovasc Surg 147(2):568–575. doi:10.1016/j.jtcvs.2013.10.006 CrossRefPubMed Onorati F, D’Errigo P, Grossi C, Barbanti M, Ranucci M, Covello DR, Rosato S, Maraschini A, Santoro G, Tamburino C, Seccareccia F, Santini F, Menicanti L, Group OR (2014) Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study. J Thorac Cardiovasc Surg 147(2):568–575. doi:10.​1016/​j.​jtcvs.​2013.​10.​006 CrossRefPubMed
26.
Zurück zum Zitat Illmann A, Riemer T, Erbel R, Giannitsis E, Hamm C, Haude M, Heusch G, Maier LS, Munzel T, Schmitt C, Schumacher B, Senges J, Voigtlander T, Mudra H (2014) Disease distribution and outcome in troponin-positive patients with or without revascularization in a chest pain unit: results of the German CPU-Registry. Clin Res Cardiol 103(1):29–40. doi:10.1007/s00392-013-0619-5 CrossRefPubMed Illmann A, Riemer T, Erbel R, Giannitsis E, Hamm C, Haude M, Heusch G, Maier LS, Munzel T, Schmitt C, Schumacher B, Senges J, Voigtlander T, Mudra H (2014) Disease distribution and outcome in troponin-positive patients with or without revascularization in a chest pain unit: results of the German CPU-Registry. Clin Res Cardiol 103(1):29–40. doi:10.​1007/​s00392-013-0619-5 CrossRefPubMed
27.
28.
Zurück zum Zitat Zeymer U, Arntz HR, Mark B, Fichtlscherer S, Werner G, Scholler R, Zahn R, Diller F, Darius H, Dill T, Huber K (2012) Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial. Clin Res Cardiol 101(4):305–312. doi:10.1007/s00392-011-0393-1 CrossRefPubMed Zeymer U, Arntz HR, Mark B, Fichtlscherer S, Werner G, Scholler R, Zahn R, Diller F, Darius H, Dill T, Huber K (2012) Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial. Clin Res Cardiol 101(4):305–312. doi:10.​1007/​s00392-011-0393-1 CrossRefPubMed
29.
Zurück zum Zitat Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Mudrick DW, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernandez-Hidalgo N, Nacinovich F, Rizk H, Krajinovic V, Giannitsioti E, Hurley JP, Hannan MM, Wang A (2014) The association between surgical indications, operative risk and clinical outcome in infective endocarditis: a prospective study from the international collaboration on endocarditis. Circulation. doi:10.1161/CIRCULATIONAHA.114.012461 PubMedCentral Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Mudrick DW, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernandez-Hidalgo N, Nacinovich F, Rizk H, Krajinovic V, Giannitsioti E, Hurley JP, Hannan MM, Wang A (2014) The association between surgical indications, operative risk and clinical outcome in infective endocarditis: a prospective study from the international collaboration on endocarditis. Circulation. doi:10.​1161/​CIRCULATIONAHA.​114.​012461 PubMedCentral
30.
Zurück zum Zitat Kulik A, Masters RG, Bedard P, Hendry PJ, Lam BK, Rubens FD, Mesana TG, Ruel M (2010) Postoperative lipid-lowering therapy and bioprosthesis structural valve deterioration: justification for a randomised trial? Eur J Cardiothorac Surg 37(1):139–144. doi:10.1016/j.ejcts.2009.06.051 CrossRefPubMed Kulik A, Masters RG, Bedard P, Hendry PJ, Lam BK, Rubens FD, Mesana TG, Ruel M (2010) Postoperative lipid-lowering therapy and bioprosthesis structural valve deterioration: justification for a randomised trial? Eur J Cardiothorac Surg 37(1):139–144. doi:10.​1016/​j.​ejcts.​2009.​06.​051 CrossRefPubMed
31.
Zurück zum Zitat Pullan M, Chalmers J, Mediratta N, Shaw M, McShane J, Poullis M (2014) Statins and long-term survival after isolated valve surgery: the importance of valve type, position and procedure. Eur J Cardiothorac Surg 45(3):419–424. doi:10.1093/ejcts/ezt399 (discussion 424–415) CrossRefPubMed Pullan M, Chalmers J, Mediratta N, Shaw M, McShane J, Poullis M (2014) Statins and long-term survival after isolated valve surgery: the importance of valve type, position and procedure. Eur J Cardiothorac Surg 45(3):419–424. doi:10.​1093/​ejcts/​ezt399 (discussion 424–415) CrossRefPubMed
32.
Zurück zum Zitat Flameng W, Rega F, Vercalsteren M, Herijgers P, Meuris B (2014) Antimineralization treatment and patient-prosthesis mismatch are major determinants of the onset and incidence of structural valve degeneration in bioprosthetic heart valves. J Thorac Cardiovasc Surg 147(4):1219–1224. doi:10.1016/j.jtcvs.2013.03.025 CrossRefPubMed Flameng W, Rega F, Vercalsteren M, Herijgers P, Meuris B (2014) Antimineralization treatment and patient-prosthesis mismatch are major determinants of the onset and incidence of structural valve degeneration in bioprosthetic heart valves. J Thorac Cardiovasc Surg 147(4):1219–1224. doi:10.​1016/​j.​jtcvs.​2013.​03.​025 CrossRefPubMed
33.
Zurück zum Zitat Pibarot P, Weissman NJ, Stewart WJ, Hahn RT, Lindman BR, McAndrew T, Kodali SK, Mack MJ, Thourani VH, Miller DC, Svensson LG, Herrmann HC, Smith CR, Rodes-Cabau J, Webb J, Lim S, Xu K, Hueter I, Douglas PS, Leon MB (2014) Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort–a analysis. J Am Coll Cardiol 64(13):1323–1334. doi:10.1016/j.jacc.2014.06.1195 PubMedCentralCrossRefPubMed Pibarot P, Weissman NJ, Stewart WJ, Hahn RT, Lindman BR, McAndrew T, Kodali SK, Mack MJ, Thourani VH, Miller DC, Svensson LG, Herrmann HC, Smith CR, Rodes-Cabau J, Webb J, Lim S, Xu K, Hueter I, Douglas PS, Leon MB (2014) Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort–a analysis. J Am Coll Cardiol 64(13):1323–1334. doi:10.​1016/​j.​jacc.​2014.​06.​1195 PubMedCentralCrossRefPubMed
35.
Zurück zum Zitat Dalen M, Biancari F, Rubino AS, Santarpino G, De Praetere H, Kasama K, Juvonen T, Deste W, Pollari F, Meuris B, Fischlein T, Mignosa C, Gatti G, Pappalardo A, Sartipy U, Svenarud P (2014) Ministernotomy versus full sternotomy aortic valve replacement with a sutureless bioprosthesis: a multicenter study. Ann Thorac Surg. doi:10.1016/j.athoracsur.2014.08.028 Dalen M, Biancari F, Rubino AS, Santarpino G, De Praetere H, Kasama K, Juvonen T, Deste W, Pollari F, Meuris B, Fischlein T, Mignosa C, Gatti G, Pappalardo A, Sartipy U, Svenarud P (2014) Ministernotomy versus full sternotomy aortic valve replacement with a sutureless bioprosthesis: a multicenter study. Ann Thorac Surg. doi:10.​1016/​j.​athoracsur.​2014.​08.​028
36.
Zurück zum Zitat Miceli A, Murzi M, Gilmanov D, Fuga R, Ferrarini M, Solinas M, Glauber M (2014) Minimally invasive aortic valve replacement using right minithoracotomy is associated with better outcomes than ministernotomy. J Thorac Cardiovasc Surg 148(1):133–137. doi:10.1016/j.jtcvs.2013.07.060 CrossRefPubMed Miceli A, Murzi M, Gilmanov D, Fuga R, Ferrarini M, Solinas M, Glauber M (2014) Minimally invasive aortic valve replacement using right minithoracotomy is associated with better outcomes than ministernotomy. J Thorac Cardiovasc Surg 148(1):133–137. doi:10.​1016/​j.​jtcvs.​2013.​07.​060 CrossRefPubMed
38.
Zurück zum Zitat Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, Hung JW, Parides MK, Ailawadi G, Perrault LP, Acker MA, Argenziano M, Thourani V, Gammie JS, Miller MA, Page P, Overbey JR, Bagiella E, Dagenais F, Blackstone EH, Kron IL, Goldstein DJ, Rose EA, Moquete EG, Jeffries N, Gardner TJ, O’Gara PT, Alexander JH, Michler RE, Cardiothoracic Surgical Trials Network I (2014) Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 371(23):2178–2188. doi:10.1056/NEJMoa1410490 PubMedCentralCrossRefPubMed Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, Hung JW, Parides MK, Ailawadi G, Perrault LP, Acker MA, Argenziano M, Thourani V, Gammie JS, Miller MA, Page P, Overbey JR, Bagiella E, Dagenais F, Blackstone EH, Kron IL, Goldstein DJ, Rose EA, Moquete EG, Jeffries N, Gardner TJ, O’Gara PT, Alexander JH, Michler RE, Cardiothoracic Surgical Trials Network I (2014) Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 371(23):2178–2188. doi:10.​1056/​NEJMoa1410490 PubMedCentralCrossRefPubMed
39.
Zurück zum Zitat Yin L, Wang Z, Shen H, Min J, Ling X, Xi W (2014) Coronary artery bypass grafting versus combined coronary artery bypass grafting and mitral valve repair in treating ischaemic mitral regurgitation: a meta-analysis. Heart Lung Circ 23(10):905–912. doi:10.1016/j.hlc.2014.03.031 CrossRefPubMed Yin L, Wang Z, Shen H, Min J, Ling X, Xi W (2014) Coronary artery bypass grafting versus combined coronary artery bypass grafting and mitral valve repair in treating ischaemic mitral regurgitation: a meta-analysis. Heart Lung Circ 23(10):905–912. doi:10.​1016/​j.​hlc.​2014.​03.​031 CrossRefPubMed
40.
Zurück zum Zitat Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D’Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O’Gara PT, Michler RE, Kron Ctsn IL (2014) Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 370(1):23–32. doi:10.1056/NEJMoa1312808 PubMedCentralCrossRefPubMed Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D’Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O’Gara PT, Michler RE, Kron Ctsn IL (2014) Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 370(1):23–32. doi:10.​1056/​NEJMoa1312808 PubMedCentralCrossRefPubMed
41.
Zurück zum Zitat MacHaalany J, Senechal M, O’Connor K, Abdelaal E, Plourde G, Voisine P, Rimac G, Tardif MA, Costerousse O, Bertrand OF (2014) Early and late mortality after repair or replacement in mitral valve prolapse and functional ischemic mitral regurgitation: a systematic review and meta-analysis of observational studies. Int J Cardiol 173(3):499–505. doi:10.1016/j.ijcard.2014.02.029 CrossRefPubMed MacHaalany J, Senechal M, O’Connor K, Abdelaal E, Plourde G, Voisine P, Rimac G, Tardif MA, Costerousse O, Bertrand OF (2014) Early and late mortality after repair or replacement in mitral valve prolapse and functional ischemic mitral regurgitation: a systematic review and meta-analysis of observational studies. Int J Cardiol 173(3):499–505. doi:10.​1016/​j.​ijcard.​2014.​02.​029 CrossRefPubMed
43.
Zurück zum Zitat Boekstegers P, Hausleiter J, Baldus S, von Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schafer U, Schillinger W, Wunderlich N, Germany Society of Cardiology Working Group on Interventional Cardiology Focus Group on Interventional Mitral Valve T (2014) Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol 103(2):85–96. doi:10.1007/s00392-013-0614-x CrossRef Boekstegers P, Hausleiter J, Baldus S, von Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schafer U, Schillinger W, Wunderlich N, Germany Society of Cardiology Working Group on Interventional Cardiology Focus Group on Interventional Mitral Valve T (2014) Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol 103(2):85–96. doi:10.​1007/​s00392-013-0614-x CrossRef
44.
Zurück zum Zitat Ledwoch J, Franke J, Baldus S, Schillinger W, Bekeredjian R, Boekstegers P, Hink U, Kuck KH, Ouarrak T, Mollmann H, Nickenig G, Senges J, Franzen O, Sievert H (2014) Impact of the learning curve on outcome after transcatheter mitral valve repair: results from the German Mitral Valve Registry. Clin Res Cardiol 103(11):930–937. doi:10.1007/s00392-014-0734-y CrossRefPubMed Ledwoch J, Franke J, Baldus S, Schillinger W, Bekeredjian R, Boekstegers P, Hink U, Kuck KH, Ouarrak T, Mollmann H, Nickenig G, Senges J, Franzen O, Sievert H (2014) Impact of the learning curve on outcome after transcatheter mitral valve repair: results from the German Mitral Valve Registry. Clin Res Cardiol 103(11):930–937. doi:10.​1007/​s00392-014-0734-y CrossRefPubMed
45.
Zurück zum Zitat Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, American College of Cardiology/American Heart Association Task Force on Practice G (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(22):e57–185. doi:10.1016/j.jacc.2014.02.536 CrossRefPubMed Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, American College of Cardiology/American Heart Association Task Force on Practice G (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(22):e57–185. doi:10.​1016/​j.​jacc.​2014.​02.​536 CrossRefPubMed
46.
Zurück zum Zitat Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, Whitlow PL, Rinaldi MJ, Grayburn P, Mack MJ, Mauri L, McCarthy PM, Feldman T (2014) Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol 64(2):172–181. doi:10.1016/j.jacc.2013.12.062 CrossRefPubMed Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, Whitlow PL, Rinaldi MJ, Grayburn P, Mack MJ, Mauri L, McCarthy PM, Feldman T (2014) Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol 64(2):172–181. doi:10.​1016/​j.​jacc.​2013.​12.​062 CrossRefPubMed
47.
Zurück zum Zitat Lim DS, Reynolds MR, Feldman T, Kar S, Herrmann HC, Wang A, Whitlow PL, Gray WA, Grayburn P, Mack MJ, Glower DD (2014) Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol 64(2):182–192. doi:10.1016/j.jacc.2013.10.021 CrossRefPubMed Lim DS, Reynolds MR, Feldman T, Kar S, Herrmann HC, Wang A, Whitlow PL, Gray WA, Grayburn P, Mack MJ, Glower DD (2014) Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol 64(2):182–192. doi:10.​1016/​j.​jacc.​2013.​10.​021 CrossRefPubMed
49.
Zurück zum Zitat Nasso G, Bonifazi R, Romano V, Bartolomucci F, Rosano G, Massari F, Fattouch K, Del Prete G, Riccioni G, Del Giglio M, Speziale G (2014) Three-year results of repaired Barlow mitral valves via right minithoracotomy versus median sternotomy in a randomized trial. Cardiology 128(2):97–105. doi:10.1159/000357263 CrossRefPubMed Nasso G, Bonifazi R, Romano V, Bartolomucci F, Rosano G, Massari F, Fattouch K, Del Prete G, Riccioni G, Del Giglio M, Speziale G (2014) Three-year results of repaired Barlow mitral valves via right minithoracotomy versus median sternotomy in a randomized trial. Cardiology 128(2):97–105. doi:10.​1159/​000357263 CrossRefPubMed
51.
Zurück zum Zitat Kim JB, Spevack DM, Tunick PA, Bullinga JR, Kronzon I, Chinitz LA, Reynolds HR (2008) The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr 21(3):284–287. doi:10.1016/j.echo.2007.05.022 CrossRefPubMed Kim JB, Spevack DM, Tunick PA, Bullinga JR, Kronzon I, Chinitz LA, Reynolds HR (2008) The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr 21(3):284–287. doi:10.​1016/​j.​echo.​2007.​05.​022 CrossRefPubMed
52.
Zurück zum Zitat Ratschiller T, Guenther T, Knappich C, Guenzinger R, Kehl V, Voss B, Lange R (2014) Do transvalvular pacemaker leads influence functional outcome after tricuspid ring annuloplasty? Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezu449 PubMed Ratschiller T, Guenther T, Knappich C, Guenzinger R, Kehl V, Voss B, Lange R (2014) Do transvalvular pacemaker leads influence functional outcome after tricuspid ring annuloplasty? Eur J Cardiothorac Surg. doi:10.​1093/​ejcts/​ezu449 PubMed
53.
Zurück zum Zitat Goldstone AB, Howard JL, Cohen JE, MacArthur JW Jr, Atluri P, Kirkpatrick JN, Woo YJ (2014) Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: implications for future guidelines. J Thorac Cardiovasc Surg 148(6):2802–2810. doi:10.1016/j.jtcvs.2014.08.001 CrossRefPubMed Goldstone AB, Howard JL, Cohen JE, MacArthur JW Jr, Atluri P, Kirkpatrick JN, Woo YJ (2014) Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: implications for future guidelines. J Thorac Cardiovasc Surg 148(6):2802–2810. doi:10.​1016/​j.​jtcvs.​2014.​08.​001 CrossRefPubMed
54.
Zurück zum Zitat Rajbanshi BG, Suri RM, Nkomo VT, Dearani JA, Daly RC, Burkhart HM, Stulak JM, Joyce LD, Li Z, Schaff HV (2014) Influence of mitral valve repair versus replacement on the development of late functional tricuspid regurgitation. J Thorac Cardiovasc Surg 148(5):1957–1962. doi:10.1016/j.jtcvs.2014.04.041 CrossRefPubMed Rajbanshi BG, Suri RM, Nkomo VT, Dearani JA, Daly RC, Burkhart HM, Stulak JM, Joyce LD, Li Z, Schaff HV (2014) Influence of mitral valve repair versus replacement on the development of late functional tricuspid regurgitation. J Thorac Cardiovasc Surg 148(5):1957–1962. doi:10.​1016/​j.​jtcvs.​2014.​04.​041 CrossRefPubMed
55.
Zurück zum Zitat Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451–2496. doi:10.1093/eurheartj/ehs109 CrossRef Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451–2496. doi:10.​1093/​eurheartj/​ehs109 CrossRef
56.
Zurück zum Zitat Addetia K, Maffessanti F, Mediratta A, Yamat M, Weinert L, Moss JD, Nayak HM, Burke MC, Patel AR, Kruse E, Jeevanandam V, Mor-Avi V, Lang RM (2014) Impact of implantable transvenous device lead location on severity of tricuspid regurgitation. J Am Soc Echocardiogr 27(11):1164–1175. doi:10.1016/j.echo.2014.07.004 PubMedCentralCrossRefPubMed Addetia K, Maffessanti F, Mediratta A, Yamat M, Weinert L, Moss JD, Nayak HM, Burke MC, Patel AR, Kruse E, Jeevanandam V, Mor-Avi V, Lang RM (2014) Impact of implantable transvenous device lead location on severity of tricuspid regurgitation. J Am Soc Echocardiogr 27(11):1164–1175. doi:10.​1016/​j.​echo.​2014.​07.​004 PubMedCentralCrossRefPubMed
57.
Zurück zum Zitat Starling RC, Moazami N, Silvestry SC, Ewald G, Rogers JG, Milano CA, Rame JE, Acker MA, Blackstone EH, Ehrlinger J, Thuita L, Mountis MM, Soltesz EG, Lytle BW, Smedira NG (2014) Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 370(1):33–40. doi:10.1056/NEJMoa1313385 CrossRefPubMed Starling RC, Moazami N, Silvestry SC, Ewald G, Rogers JG, Milano CA, Rame JE, Acker MA, Blackstone EH, Ehrlinger J, Thuita L, Mountis MM, Soltesz EG, Lytle BW, Smedira NG (2014) Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 370(1):33–40. doi:10.​1056/​NEJMoa1313385 CrossRefPubMed
58.
Zurück zum Zitat Boyle AJ, Jorde UP, Sun B, Park SJ, Milano CA, Frazier OH, Sundareswaran KS, Farrar DJ, Russell SD, HeartMate IICI (2014) Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. J Am Coll Cardiol 63(9):880–888. doi:10.1016/j.jacc.2013.08.1656 CrossRefPubMed Boyle AJ, Jorde UP, Sun B, Park SJ, Milano CA, Frazier OH, Sundareswaran KS, Farrar DJ, Russell SD, HeartMate IICI (2014) Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. J Am Coll Cardiol 63(9):880–888. doi:10.​1016/​j.​jacc.​2013.​08.​1656 CrossRefPubMed
59.
Zurück zum Zitat Milano C, Pagani FD, Slaughter MS, Pham DT, Hathaway DR, Jacoski MV, Najarian KB, Aaronson KD, Investigators A (2014) Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures. Circulation 130(11 Suppl 1):S3–11. doi:10.1161/CIRCULATIONAHA.113.007911 CrossRefPubMed Milano C, Pagani FD, Slaughter MS, Pham DT, Hathaway DR, Jacoski MV, Najarian KB, Aaronson KD, Investigators A (2014) Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures. Circulation 130(11 Suppl 1):S3–11. doi:10.​1161/​CIRCULATIONAHA.​113.​007911 CrossRefPubMed
60.
Zurück zum Zitat Fujita T, Kobayashi J, Hata H, Seguchi O, Murata Y, Yanase M, Nakatani T (2014) Right heart failure and benefits of adjuvant tricuspid valve repair in patients undergoing left ventricular assist device implantation. Eur J Cardiothorac Surg 46(5):802–807. doi:10.1093/ejcts/ezu040 CrossRefPubMed Fujita T, Kobayashi J, Hata H, Seguchi O, Murata Y, Yanase M, Nakatani T (2014) Right heart failure and benefits of adjuvant tricuspid valve repair in patients undergoing left ventricular assist device implantation. Eur J Cardiothorac Surg 46(5):802–807. doi:10.​1093/​ejcts/​ezu040 CrossRefPubMed
61.
Zurück zum Zitat Brewer RJ, Cabrera R, El-Atrache M, Zafar A, Hrobowski TN, Nemeh HM, Selektor Y, Paone G, Williams CT, Velez M, Tita C, Morgan JA, Lanfear DE (2014) Relationship of tricuspid repair at the time of left ventricular assist device implantation and survival. Int J Artificial Organs 37(11):834–838. doi:10.5301/ijao.5000369 CrossRef Brewer RJ, Cabrera R, El-Atrache M, Zafar A, Hrobowski TN, Nemeh HM, Selektor Y, Paone G, Williams CT, Velez M, Tita C, Morgan JA, Lanfear DE (2014) Relationship of tricuspid repair at the time of left ventricular assist device implantation and survival. Int J Artificial Organs 37(11):834–838. doi:10.​5301/​ijao.​5000369 CrossRef
63.
Zurück zum Zitat Lalonde SD, Alba AC, Rigobon A, Ross HJ, Delgado DH, Billia F, McDonald M, Cusimano RJ, Yau TM, Rao V (2013) Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD. J Card Surg 28(5):604–610. doi:10.1111/jocs.12158 CrossRefPubMed Lalonde SD, Alba AC, Rigobon A, Ross HJ, Delgado DH, Billia F, McDonald M, Cusimano RJ, Yau TM, Rao V (2013) Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD. J Card Surg 28(5):604–610. doi:10.​1111/​jocs.​12158 CrossRefPubMed
64.
Zurück zum Zitat Pulikottil-Jacob R, Suri G, Connock M, Kandala NB, Sutcliffe P, Maheswaran H, Banner NR, Clarke A (2014) Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure. J Heart Lung Transplant 33(4):350–358. doi:10.1016/j.healun.2014.01.003 CrossRefPubMed Pulikottil-Jacob R, Suri G, Connock M, Kandala NB, Sutcliffe P, Maheswaran H, Banner NR, Clarke A (2014) Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure. J Heart Lung Transplant 33(4):350–358. doi:10.​1016/​j.​healun.​2014.​01.​003 CrossRefPubMed
66.
Zurück zum Zitat Kansara P, Czer L, Awad M, Arabia F, Mirocha J, De Robertis M, Moriguchi J, Ramzy D, Kass RM, Esmailian F, Trento A, Kobashigawa J (2014) Heart transplantation with and without prior sternotomy: analysis of the United Network for Organ Sharing database. Transplant Proc 46(1):249–255. doi:10.1016/j.transproceed.2013.09.027 CrossRefPubMed Kansara P, Czer L, Awad M, Arabia F, Mirocha J, De Robertis M, Moriguchi J, Ramzy D, Kass RM, Esmailian F, Trento A, Kobashigawa J (2014) Heart transplantation with and without prior sternotomy: analysis of the United Network for Organ Sharing database. Transplant Proc 46(1):249–255. doi:10.​1016/​j.​transproceed.​2013.​09.​027 CrossRefPubMed
67.
Zurück zum Zitat Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwoger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, Allmen RS, Vrints CJ, Guidelines ESCCfP (2014) 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 35(41):2873–2926. doi:10.1093/eurheartj/ehu281 CrossRefPubMed Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwoger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, Allmen RS, Vrints CJ, Guidelines ESCCfP (2014) 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 35(41):2873–2926. doi:10.​1093/​eurheartj/​ehu281 CrossRefPubMed
68.
Zurück zum Zitat De Paulis R, Czerny M, Weltert L, Bavaria J, Borger MA, Carrel TP, Etz CD, Grimm M, Loubani M, Pacini D, Resch T, Urbanski PP, Weigang E (2014) Current trends in cannulation and neuroprotection during surgery of the aortic arch in Europedaggerdouble dagger. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezu284 PubMed De Paulis R, Czerny M, Weltert L, Bavaria J, Borger MA, Carrel TP, Etz CD, Grimm M, Loubani M, Pacini D, Resch T, Urbanski PP, Weigang E (2014) Current trends in cannulation and neuroprotection during surgery of the aortic arch in Europedaggerdouble dagger. Eur J Cardiothorac Surg. doi:10.​1093/​ejcts/​ezu284 PubMed
Metadaten
Titel
Cardiac surgery 2014 reviewed
verfasst von
Torsten Doenst
Constanze Strüning
Alexandros Moschovas
David Gonzalez-Lopez
Ilija Valchanov
Hristo Kirov
Mahmoud Diab
Gloria Faerber
Publikationsdatum
01.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 12/2015
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-015-0914-4

Weitere Artikel der Ausgabe 12/2015

Clinical Research in Cardiology 12/2015 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.